| COS Unique Id: |
112724 |
| Title: |
Ocean Biology and Biogeochemistry (2008) |
| Sponsor: |
National Aeronautics and Space Administration (NASA)
Research Opportunities in Space and Earth Sciences (ROSES) - 2008
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 2, 2008
|
| Deadline Note: |
Non-required notices of intent are due by April 1, 2008. The deadline for submission of proposals is June 2, 2008. |
| Amount Note: |
Up to $2.5 Million is available to support 10 to 20 awards for periods of up to four years. |
| Eligibility: |
Participation in this program is open to all
categories of U.S. and non-U.S. organizations, including educational
institutions, industry, nonprofit institutions, NASA Centers, and other
government agencies. Historically Black Colleges and Universities
(HBCU's), other minority educational institutions, and small businesses
and organizations owned and controlled by socially and economically
disadvantaged individuals or women are particularly encouraged to
apply. Participation by non-U.S. organizations in this program is
encouraged subject to NASA's policy of no-exchange-of-funds. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
NASA's Ocean Biology and Biogeochemistry program
focuses on describing, understanding, and predicting the biological and
biogeochemical regimes of the upper ocean as determined by remote
observation of aquatic optical properties from space, aircraft, and
other suborbital platforms. Main goals include the following:
1.
Understanding and quantifying the impacts and feedbacks of Earth System
processes, particularly oceanographic mechanisms, on the global and
regional spatial and temporal variability of ocean biology, including
phytoplankton and organisms from other trophic levels
2.
Understanding and quantifying the impacts and feedbacks of Earth System
processes, particularly oceanographic mechanisms, on the global and
regional spatial and temporal variability of ocean biogeochemistry,
including carbon sources and sinks and the fate of other chemical
species or constituents in the ocean
3. Exploring the development of
new biological and biogeochemical observations beyond traditional ocean
color (e.g., phytoplankton chlorophyll a) from space-based assets, as
well as furthering the climate research enabled by existing time series
of climate observations (Earth System Data Records)
4. Improving
future climate predictions (impacts and feedbacks) by incorporating a
dynamic understanding of ocean biology and biogeochemistry into global
biogeochemical and ecological models to understand the ocean's role in
the Earth System |
| Contact Name: |
Dr. Paula Bontempi |
| Contact Address: |
Earth Science Division
Science Mission Directorate
NASA Headquarters |
| Contact City: |
Washington |
| Contact State: |
District of Columbia |
| Contact Zip: |
20546-0001 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (202) 358-1508 |
| Contact Email: |
Paula.S.Bontempi@nasa.gov |
| URL for more information: |
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId=%7BA14A0768-C567-7398-CBF6-CF9EF39077C8%7D&path=open |
| Date Last Revised: |
February 19, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=112724 |
| Keywords: |
Biogeochemistry
Biological Oceanography
Climatology
Marine Biology
Marine Ecology
Ocean Surveillance
Physical Oceanography
Weather Prediction or Forecasting
|
| Sponsor Reference No: |
NNH08ZDA001N-OBB |
| Funding Type: |
Research
|
| COS Unique Id: |
112751 |
| Title: |
Methods for Prevention Packages Program (MP3) (R01) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
July 15, 2008
|
| Deadline Note: |
The opening date is May 16, 2008. An optional letter of intent is due June 16, 2008. This opportunity expires July 16, 2008. |
| Upper Amount: |
$2,400,000 |
| Amount Note: |
This FOA will utilize the NIH Research Project
Grant (R01) award mechanism. The NIAID intends to award up to $4
million in FY 2009 to fund four to six applications submitted in
response to this FOA. NIMH is also providing $500,000 in support of
this FOA. Applicants may request a project period of up to four years
and a budget of up to $600,000 in direct costs in each year, plus
applicable facilities and administrative costs.
This program does not require cost sharing. |
| Eligibility: |
Applications may be submitted by domestic or
foreign, for-profit or nonprofit organizations and public or private
institutions, such as universities, colleges, hospitals, and
laboratories; units of state and local governments; eligible agencies
of the federal government; and faith-based or community-based
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The National Institute of Allergy and Infectious
Diseases (NIAID) and the National Institute of Mental Health (NIMH)
invite applications for multidisciplinary research programs that
- devise optimal HIV prevention packages (combination interventions) for specific populations,
- design clinical studies to rigorously examine the safety and efficacy of these "packages" in the target population, and
-
perform pilot studies to demonstrate that the proposed prevention
package is acceptable to the target population and the study design is
appropriate and feasible. This funding opportunity announcement (FOA)
is intended to encourage collaborations between behavioral and
biomedical clinical scientists, epidemiologists, mathematical modelers,
and clinical trial design specialists.
It is expected that teams
conducting this research will perform a systematic review and
meta-analysis of existing prevention research data germane to the
target population(s) chosen. These data should be used to develop a
mathematical model to assess the impact of various combinations of
interventions which have been shown to reduce HIV incidence in the same
or similar settings. A range of estimates may be considered for new
interventions for which efficacy data is lacking but is expected to
become available in the near future.
Sensitivity analyses
showing how the outcome is influenced by key risk behaviors and other
variables (e.g., stage of the epidemic, dominant modes of transmission
in the population, proportion of persons in major risk groups, etc., as
appropriate) should be provided. The impact of incomplete adherence,
risk compensation, and other behavioral factors should also be
considered. A full discussion of the key assumptions of the
mathematical model should be provided.
The prevention packages
should include both biomedical and behavioral interventions that can be
applied in a complementary manner in the target population. As
indicated, interventions to optimize adherence and minimize
disinhibition (risk compensation) should be included. The population
selected may be a specific high-risk group, such as African American
men who have sex with men (MSM) or injection drug users in Eastern
Europe; a nation as a whole, such as the population of Thailand, with
its specific combination of risk groups, risk behaviors, and incidence
rates; or a region, such as southern Africa. The latter approach is
justifiable if the population can be shown to be relatively uniform
with regard to HIV risk groups and other key variables. Mathematical
models based on data for one country or region should be tested, if
possible, using data from another similar country or region.
The
team should carefully examine the strengths and limitations of the
research design chosen to evaluate the proposed prevention package(s),
making comparisons with alternative designs. The control intervention
should include HIV risk reduction counseling, free condoms, and other
behavioral and biomedical interventions considered standard of care.
Finally,
the team should (a) perform a pilot study to demonstrate that the
proposed prevention package is acceptable to the target population, and
(b) present convincing evidence that the research design proposed is
feasible operationally and will provide a conclusive assessment of the
prevention package's safety and efficacy. The latter should include
evidence that sufficient HIV incidence events will occur in the
proposed setting, sample population, and follow-up period. A phase 1
clinical study may be adequate to demonstrate that the prevention
package is acceptable to the target population. Applicants are
encouraged to discuss the scope of the pilot study with NIAID program
staff prior to submission. |
| Contact Name: |
Lisa Scott-Morring, M.S. |
| Contact Address: |
Division of Extramural Activities
Room 2232, MSC-7614
6700B Rockledge Drive |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-7614 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 451-3697 |
| Contact Fax: |
+1 (301) 493-0597 |
| Contact Email: |
ScottLi@niaid.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/rfa-files/RFA-AI-08-019.html |
| Date Last Revised: |
February 21, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=112751 |
| Keywords: |
HIV Prevention
|
| Funding Type: |
Collaboration or Cooperative Agreement
Research
|
| COS Unique Id: |
112753 |
| Title: |
Molecular Phenotypes for Lung Diseases (R01) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
May 5, 2008
|
| Deadline Note: |
An optional letter of intent is due April 5, 2008. This opportunity expires May 6, 2008.
Internal coordination required. Applicants may not submit more than one application. |
| Upper Amount: |
$2,000,000 |
| Amount Note: |
This FOA will utilize the NIH Research Project
Grant (R01) award mechanism. Contingent upon the availability of funds
and the receipt of a sufficient number of meritorious applications, the
total amount of $16 million will be used to fund up to six awards of
four years' duration. Applicants may request direct costs up to
$500,000 annually for four years.
This program does not require cost sharing. |
| Eligibility: |
Applications may be submitted by domestic or
foreign, for-profit or nonprofit organizations and public or private
institutions, such as universities, colleges, hospitals, and
laboratories; units of state and local governments; eligible agencies
of the federal government; and faith-based or community-based
organizations.
Each application must include a team of experts
in the fields of pulmonary diseases, genetics, high-throughput
technology, and bioinformatics or statistics in order to merge clinical
observations and molecular readouts into an integrated view for the
study of lung disease. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The National Heart, Lung, and Blood Institute
(NHLBI) solicits grant applications under this funding opportunity
announcement (FOA) to stimulate research that will define or
subcategorize human lung diseases at a molecular level enabling early
diagnosis, prognosis, and personalized treatment of these diseases. The
measurement of whole-genome gene expression at the RNA level will be
the primary approach to systematically collect molecular phenotyping
data for common and rare lung diseases. In addition, this FOA
encourages the integration of data from other omics approaches (e.g.,
genomics, epigenomics, etc.) to reinforce or validate findings from RNA
expression. The data generated from this program will be made available
to the broad scientific community.
Applicants must clearly
define a plan for the selection of the disease population; study
design, including selection of appropriate controls; quality control of
sample collection process and gene expression measurements; and
proposed analyses.
Choice of population and study design
should be justified by the scientific questions addressed by each
application, such as the disease, subcategorizing disease, and response
to treatment. The chosen control population must be appropriate for the
proposed study design. Applicants must obtain biospecimens and
phenotype data from existing or ongoing cohort, clinical, and family
studies of lung diseases and are expected to provide details about the
population necessary to justify the study design. The funding under
this FOA can be used to support sample collection (e.g., RNA, protein,
or metabolites) if necessary. Recruitment of new subjects will not be
supported. Applicants are expected to already have access to required
major instruments and IT infrastructures needed to accomplish the goals
of this FOA.
Research topics that can be addressed as part of this initiative include, but are not limited to, the following:
1. Stratification of clinical subtypes based on gene expression profiles
2.
Analyses of mRNA expression in response to specific exposures or
pharmacologic treatment of lung diseases to better subcategorize lung
diseases
3. Studies that integrate gene expression data with
cross-sectional and longitudinal, quantitative data or discrete lung
phenotypes as a means to refine phenotype definitions based on
expression profiles
4. Studies of genetic architecture of lung disease using expression quantitative traits (eQTL) mapping approach
5.
Studies that develop clinical prediction models based on combinations
of gene expression profiling with genetic variation data
6.
Studies that include application of in silico modeling to gene
expression profiling data to refine subcategories of lung disease
Applications focusing on lung cancer are not responsive to this FOA. |
| Contact Name: |
Ryan Lombardi |
| Contact Address: |
Division of Extramural Research Activities
National Heart, Lung, and Blood Institute
Room 7154, MSC 7926
6701 Rockledge Drive |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-7926 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 435-0144 |
| Contact Fax: |
+1 (301) 451-5462 |
| Contact Email: |
lombardr@nhlbi.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-08-006.html |
| Date Last Revised: |
February 21, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=112753 |
| Keywords: |
Medical Microbiology
Phenotype
Respiratory Diseases
|
| Sponsor Reference No: |
RFA-HL-08-006 |
| Funding Type: |
Research
|
| COS Unique Id: |
22197 |
| Title: |
SAMS Research Bursary |
| Sponsor: |
Scottish Association for Marine Science (SAMS)
|
| Sponsor Type: |
Professional Society or Association |
| Deadline: |
March 31, 2008
June 30, 2008
September 30, 2008
December 31, 2008
|
| Eligibility: |
Successful applicants must be or become members of SAMS. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
SAMS Research Bursaries are available to support
research in any marine science subject - especially if of relevance to
Scotland. In the past this bursary has often allowed visiting
scientists to spend some time working at SAMS. The bursary might
support travel, research assistance, completion of a project or capital
equipment purchase (for which SAMS reserves the right to retain
ownership). |
| Contact Name: |
Professor Graham Shimmield |
| Contact Address: |
Scottish Association for Marine Science
Dunstaffnage Marine Laboratory |
| Contact City: |
Oban, Argyll, Scotland |
| Contact Zip: |
PA37 1QA |
| Contact Country: |
United Kingdom |
| Contact Phone: |
+44 (0) 1631-559000 |
| Contact Fax: |
+44 (0) 1631-559001 |
| Contact Email: |
info@sams.ac.uk |
| URL for more information: |
http://www.sams.ac.uk/activities/bursaries |
| Date Last Revised: |
February 20, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=22197 |
| Keywords: |
Marine and Ocean Sciences
|
| Funding Type: |
Equipment or Materials Acquisition or Facility Use
Research
Travel
|
| COS Unique Id: |
22216 |
| Title: |
Postgraduate Scholarship |
| Sponsor: |
Kee Foundation, Tan Kah
|
| Sponsor Type: |
Private Foundation |
| Deadline: |
May 31, 2008
|
| Deadline Note: |
Application for scholarships is open from May 1 to May 31. |
| Amount Note: |
The scholarship amount for those studying at
overseas universities is S$10,000 while those studying at local
universities will receive S$7,000. The scholarship will be awarded
annually and is bond-free. |
| Citizenship or Residency: |
Singapore
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Graduate Student
|
| Abstract: |
These scholarships provide financial assistance to
Singapore citizens and permanent residents pursuing their full-time
master's or Ph.D. degrees at local or overseas universities. Candidates
are appraised on their academic achievements, outstanding personal
character, and bilingual capabilities. |
| Contact Address: |
Tan Kah Kee Foundation
5 Toh Tuck Link |
| Contact Zip: |
596224 |
| Contact Country: |
Singapore |
| Contact Phone: |
+65 6463-8464 |
| Contact Fax: |
+65 6462-1192 |
| URL for more information: |
http://www.tkk.wspc.com.sg/tkk/foundation/post_eng.shtml |
| Date Last Revised: |
February 18, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=22216 |
| Keywords: |
Agriculture and Food Sciences
Area Studies
Arts and Humanities
Business, Management and Commerce
Education
Energy Sciences
Engineering
Health and Medicine
Law
Natural and Physical Sciences, Mathematics and Technology
Social Sciences
|
| Funding Type: |
Training, Scholarship, or Fellowship
|
| COS Unique Id: |
92499 |
| Title: |
Decision Support through Earth Science Research Results |
| Sponsor: |
National Aeronautics and Space Administration (NASA)
Research Opportunities in Space and Earth Sciences (ROSES) - 2008
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 17, 2008
|
| Deadline Note: |
Non-required letters of intent are due by April 9, 2008. The deadline for submission of proposals is June 17, 2008. |
| Upper Amount: |
$960,000 |
| Eligibility: |
Participation in this program is open to all
categories of U.S. and non-U.S. organizations, including educational
institutions, industry, nonprofit institutions, NASA Centers, and other
government agencies. Historically Black Colleges and Universities
(HBCU's), other minority educational institutions, and small businesses
and organizations owned and controlled by socially and economically
disadvantaged individuals or women are particularly encouraged to
apply. Participation by non-U.S. organizations in this program is
encouraged subject to NASA's policy of no-exchange-of-funds. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The Applied Sciences Program seeks proposals that
develop and demonstrate innovative and practicable applications of NASA
Earth science observations and research in eight application areas:
1. Agriculture
2. Air Quality
3. Disaster Management
4. Ecosystems
5. Public Health
6. Water Resources
7. Weather
8. Climate
Proposals
that focus on improving decision making1activities for these eight
areas are encouraged, and those that focus on climate change and water
resources are particularly encouraged. |
| Contact Name: |
Mr. Lawrence Friedl |
| Contact Address: |
Applied Sciences Program
Earth Science Division
Science Mission Directorate
NASA Headquarters |
| Contact City: |
Washington |
| Contact State: |
District of Columbia |
| Contact Zip: |
20546-0001 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (202) 358-1599 |
| Contact Email: |
LFriedl@nasa.gov |
| URL for more information: |
http://nspires.nasaprs.com/external/solicitations/summary.do?method=init&solId=%7BCCEE5599-4975-1739-0252-7DAD45B6C9EF%7D&path=open |
| Date Last Revised: |
February 19, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=92499 |
| Keywords: |
Air Quality
Climate Change
Earth Sciences
Ecosystems
Water Resources Management or Planning
|
| Sponsor Reference No: |
NNH08ZDA001N-DECISIONS |
| Funding Type: |
Research
|
| COS Unique Id: |
97243 |
| Title: |
Joint ROTRF/JDRF Initiative |
| Sponsor: |
Roche Organ Transplantation Research Foundation (ROTRF)
|
| Sponsor Type: |
Private Foundation |
| Deadline: |
April 1, 2008
October 1, 2008
|
| Deadline Note: |
Submission deadlines are April 1 and October 1 each year. |
| Amount Note: |
The terms of the grant awards (amount and period of
support per grant, frequency of the awards) follows the terms of the
general ROTRF grant award competition. Currently, ROTRF's conventional
research grants are 300,000 Swiss Francs awarded for a period of three
years. |
| Eligibility: |
Established faculty members of academic staff at
universities, transplant and diabetes centres and research institutes
are eligible to apply.
Unsuccessful applicants in the joint ROTRF/JDRF initiative may still be considered for a ROTRF or JDRF grant award. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The ROTRF and the Juvenile Diabetes Research
Foundation International (JDRF) jointly fund projects in immunology and
biology research relevant to pancreatic islet transplantation, and
transplantation solutions for human Type 1 diabetes. Investigators
working in the fields of immunology and cell biology, gene therapy,
cellular engineering, stem cell research (e.g., generation of
islet/beta cell source from stem cells or other cell sources, novel
interventions leading to immune tolerance) and other approaches that
are relevant to both type 1 diabetes and transplantation, are strongly
encouraged to apply.
Research areas funded by the ROTRF/JDRF joint initiative are as follows:
- Transplantation approaches to human Type 1 diabetes
- Islet transplantation (including deceased donor islets) for therapeutic use in Type 1 diabetic patients
-
Development of new approaches (including stem cell transplantation) for
improvements of graft survival or of long-term immunosuppression in
Type 1 diabetic patients
- Cellular engineering (including gene therapy) for therapeutic use in human transplantation relevant to Types 1 diabetes
- Investigations of alternative sources of pancreatic islets/beta cells for use in transplantation
- Quantification and functional determination of islets/beta cells for use in replacement therapy |
| Contact Address: |
Roche Organ Transplantation Research Foundation
Postfach 222 |
| Contact City: |
6045 Meggen |
| Contact Country: |
Switzerland |
| Contact Phone: |
+41 (41) 377-5335 |
| Contact Fax: |
+41 (41) 377-5334 |
| Contact Email: |
admin@ROTRF.org |
| URL for more information: |
http://www.rotrf.org/grantprogramme/rotrfjdrf/index.html |
| Date Last Revised: |
February 20, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=97243 |
| Keywords: |
Biological Sciences
Cell Biology
Cell Transplantation
Diabetes
Gene Therapy
Immunology
Immunosuppression
Organ Transplantation
Stem Cells
Transplantation Immunology
|
| Funding Type: |
Research
|
|
|
©2008, ProQuest LLC All rights reserved
|
|
